Related references
Note: Only part of the references are listed.Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data
C. Zhan et al.
DISEASES OF THE ESOPHAGUS (2016)
Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma: clinical outcomes and patterns of failure
Cai-neng Cao et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Quantitative Analysis of High-Resolution Microendoscopic Images for Diagnosis of Esophageal Squamous Cell Carcinoma
Dongsuk Shin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Computed tomography-based distribution of involved lymph nodes in patients with upper esophageal cancer
M. Li et al.
CURRENT ONCOLOGY (2015)
Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy
Peng Zhang et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Gasless Laparoscopically Assisted Transhiatal Esophagectomy for Upper Esophageal Carcinoma
Ji-xiang Wu et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Cervical esophageal cancer: A population-based study
G. Daniel Grass et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus
E. Gkika et al.
DISEASES OF THE ESOPHAGUS (2014)
Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma
R. L. G. M. Blom et al.
DISEASES OF THE ESOPHAGUS (2014)
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2014)
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
Susan J. Dutton et al.
LANCET ONCOLOGY (2014)
Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis
Mina Liu et al.
RADIATION ONCOLOGY (2014)
A qualitative synthesis of the evidence behind elective lymph node irradiation in oesophageal cancer
Lien van de Voorde et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Stahl et al.
ANNALS OF ONCOLOGY (2013)
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy
Colin Schieman et al.
ANNALS OF THORACIC SURGERY (2013)
End-to-End Anastomosis After Segmental Esophagectomy for Early Stage Cervical Esophageal Carcinoma
Ziang Cao et al.
ANNALS OF THORACIC SURGERY (2013)
DETERMINING THE LYMPH NODE CLINICAL TARGET VOLUME OF UPPER ESOPHAGEAL CARCINOMA WITH COMPUTED TOMOGRAPHY
Minghuan Li et al.
ARCHIVES OF BIOLOGICAL SCIENCES (2013)
Squamous Dysplasia-The Precursor Lesion for Esophageal Squamous Cell Carcinoma
Philip R. Taylor et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+tumour-infiltrating lymphocytes
Ming Xia et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
Thomas Crosby et al.
LANCET ONCOLOGY (2013)
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell et al.
LANCET ONCOLOGY (2013)
Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma
Lingli Tu et al.
RADIATION ONCOLOGY (2013)
Diagnostic accuracy of lugol chromoendoscopy in the oesophagus in patients with head and neck cancer
Rita Carvalho et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2013)
Larynx-Preserving Limited Resection and Free Jejunal Graft For Carcinoma of the Cervical Esophagus
Hiroshi Miyata et al.
WORLD JOURNAL OF SURGERY (2013)
Efficacy Analysis of Simplified Intensity-modulated Radiotherapy with High or Conventional Dose and Concurrent Chemotherapy for Patients with Neck and Upper Thoracic Esophageal Carcinoma
Wei-Guo Zhu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Human Papillomavirus Infection and Esophageal Squamous Cell Carcinoma: A Case-Control Study
Fangcen Guo et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Pericardial and Pleural Effusions after Definitive Radiotherapy for Esophageal Cancer
Junichi Fukada et al.
JOURNAL OF RADIATION RESEARCH (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Complication following gastric pull-up reconstruction for advanced hypopharyngeal or cervical esophageal carcinoma: a 20-year review in a Chinese institute
He Shuangba et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2011)
Multi-susceptibility genes associated with the risk of the development stages of esophageal squamous cell cancer in Feicheng County
Qing Da Li et al.
BMC GASTROENTEROLOGY (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Feasibility of Involved-Field Conformal Radiotherapy for Cervical and Upper-Thoracic Esophageal Cancer
Jin-Bo Ma et al.
ONKOLOGIE (2011)
Current Management of Cervical Esophageal Cancer
Daniel King Hung Tong et al.
WORLD JOURNAL OF SURGERY (2011)
Cisplatin/Irinotecan Versus Carboplatin/Paclitaxel as Definitive Chemoradiotherapy for Locoregionally Advanced Esophageal Cancer
Bree N. Ruppert et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA: IS ELECTIVE NODAL IRRADIATION NECESSARY?
Kuai-Le Zhao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Radical Resection or Chemoradiotherapy for Cervical Esophageal Cancer?
Shah-Hwa Chou et al.
WORLD JOURNAL OF SURGERY (2010)
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
S. Lorenzen et al.
ANNALS OF ONCOLOGY (2009)
Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus
K. Ott et al.
BRITISH JOURNAL OF SURGERY (2009)
Alcohol Consumption and the Risks of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus
Nirmala Pandeya et al.
GASTROENTEROLOGY (2009)
Free Jejunal Graft for Reconstruction of Defects in the Hypopharynx and Cervical Esophagus Following the Cancer Resections
Dean Zhao et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Larynx-Preserving Esophagectomy and Jejunal Transfer for Cervical Esophageal Carcinoma
Hideki Kadota et al.
LARYNGOSCOPE (2009)
Comparison of free jejunal graft with gastric pull-up reconstruction after resection of hypopharyngeal and cervical esophageal carcinoma
Z. Ferahkose et al.
DISEASES OF THE ESOPHAGUS (2008)
An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis
Y. F. Yang et al.
DISEASES OF THE ESOPHAGUS (2008)
Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival
Shao Hui Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
Joel Tepper et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus
Louis Fenkell et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Surgical management of carcinoma of the cervical esophagus
Hiroyuki Daiko et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus
K. Kaneko et al.
BRITISH JOURNAL OF CANCER (2007)
Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus
T. Uno et al.
DISEASES OF THE ESOPHAGUS (2007)
Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma
Li-yan Xue et al.
BMC CANCER (2006)
Treatment results of radiotherapy for carcinoma of the cervical esophagus
Kazunari Yamada et al.
ACTA ONCOLOGICA (2006)
Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer
Shu-Lian Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction
HW Wang et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: A single-institution experience
Shulian Wang et al.
JOURNAL OF THORACIC ONCOLOGY (2006)
Epidemiology of head and neck cancer in the United States
Louise Davies et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2006)
Pharyngo-cervical esophageal reconstruction
S Archibald et al.
CLINICS IN PLASTIC SURGERY (2005)
Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy
Z Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Polycyclic aromatic hydrocarbon-DNA adducts determined by semiquantitative immunohistochemistry in human esophageal biopsies taken in 1985
HE van Gijssel et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2004)
Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression
MC Kimos et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Paratracheal lymph node involvement in advanced cancer of the larynx, hypopharynx, and cervical esophagus
CV Timon et al.
LARYNGOSCOPE (2003)
Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China
H Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions
MY Wu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
HPV infections and oesophageal cancer
KJ Syrjänen
JOURNAL OF CLINICAL PATHOLOGY (2002)
Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract
M Morita et al.
SURGERY (2002)
INT 0123 (radiation therapy oncology group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy
BD Minsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Changes of TGF beta 1 and TGF beta RII expression in esophageal precancerous and cancerous lesions: a study of a high-risk population in Henan, northern China
Q Zhou et al.
DISEASES OF THE ESOPHAGUS (2002)
Surgical management of carcinoma of the hypopharynx and cervical esophagus - Analysis of 209 cases
JP Triboulet et al.
ARCHIVES OF SURGERY (2001)
p53 expression in squamous dysplasia associated with carcinoma of the oesophagus: evidence for field carcinogenesis
M Yasuda et al.
BRITISH JOURNAL OF CANCER (2000)
Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy
BH Burmeister et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2000)